One Nucleus BioWednesday: Opportunities for UK Life Sciences - A US Perspective

On May 5, Chad Shear, a life sciences Principal in the San Diego office, will speak on the “Opportunities for UK Life Sciences - A US Perspective”panel atOne Nucleus’ BioWednesday Webinar Series.

Their monthly BioWednesdays bring together a broad range of their members and non-members for peer-to-peer debate around current trends, challenges, and opportunities within the sector. Panel details are below.

BioWednesday Webinar: Opportunities for UK Life Sciences – A US Perspective
Wednesday, May 5, 16:00 - 17:30 (8 - 9:30AM PT, 11AM - 12:30PM ET)

The past year has seen record investment and deal levels across the Life Sciences sector. Far from stifling investment the pandemic has seemingly turbocharged the system and not just for those actively involved in Covid-19. The UK Life Science innovation field has demonstrated its strengths with R&D, both with successful clinical studies on treatments, surveillance and diagnostics of Covid-19 variants but in non-related areas such as immune-oncology. This has not gone unnoticed by investors with the UK Life Sciences sector seeing a record breaking year of venture investment, successful IPOs and significant M&A deals. With deal values high in the US and the UK demonstrating its value, the panel will discuss what this means for the UK businesses seeking investment, licensing deals and alliances in the US.

Moderator:Mike Ward, Global Head of Thought Leadership, Clarivate


  • Chris Loryman, Senior Manager, UC San Diego Office of Innovation and Commercialization
  • Chad Shear, Principal, Fish & Richardson
  • Cathy Tralau-Stewart, Senior Director Alliances, Takeda and Visiting Scholar at Stanford
  • Jason Mellad, CEO & Co-Founder, Start Codon

To learn more,click here.